IF: 0.478
Cite Score:
0.54
THOMSON REUTERS - SCOPUS

Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence

AUTHORS

Hossein Ghanaati 2 , * , Seyed Moayed Alavian 3 , Ali Jafarian 4 , Nasser Ebrahimi Daryani 5 , Mohsen Nassiri-Toosi 5 , Amir Hossein Jalali 2 , Madjid Shakiba 2

AUTHORS INFORMATION

2 Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Iran

3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Iran

4 Hepatobilliary and Liver Transplantation Division, Faculty of Medicine, Tehran University of Medical Sciences, Iran

5 Department of Gastroenterology, Faculty of Medicine, Tehran University of Medical Sciences, Iran

ARTICLE INFORMATION

Iranian Journal of Radiology: 9 (4); 167-77
Published Online: November 19, 2012
Article Type: Review Article
Received: September 18, 2012
Accepted: October 27, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

The imaging of hepatocellular carcinoma (HCC) is challenging and plays a crucial role in the diagnosis and staging of the disease. A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC. Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable. In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated. In this paper, we aimed to review the evidence regarding imaging modalities and therapeutic interventions of HCC.

Keywords

Carcinoma Hepatocellular, Radiology Interventional, Chemoembolization Therapeutic, Iran Risk Factors

© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: